Reza Zadno

Dr. Zadno has served as PROCEPT BioRobotics President and Chief Executive Officer and a member of the board of directors since February 2020. Prior to joining PROCEPT BioRobotics Dr. Zadno served as President and Chief Executive Officer of Avedro, Inc., an ophthalmology company that developed a proprietary Corneal Remodeling Platform Technology. During his time at Avedro, Inc. from September 2016 to November 2020, he led the company through an IPO and rapid commercialization, and ultimately an acquisition by Glaukos; he also served as a member of the board of directors at Avedro. Prior to Avedro, Dr. Zadno served as Innovation Advisor and Venture Partner at InterWest Partners, a venture capital firm, from January 2012 to January 2018. Dr. Zadno has also served on the boards of directors of Invuity, Inc. from January 2013 to June 2017, where he was a member of the audit committee, and Carbylan Therapeutics, Inc. from June 2013 to November 2016, where he was a member of the audit committee. Dr. Zadno also served on the Board of a number of additional private companies. Dr. Zadno also co-founded PercuSurge, a maker of distal protection devices used in treating occluded carotid arteries and saphenous vein grafts, which was acquired by Medtronic. Dr. Zadno received both a Ph.D. and an M.Sc. in Mechanical Properties of Materials from École Nationale Supérieure des Mines de Paris.